Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis
The expanding role of ERAs in nephrology underscores their potential in treating proteinuric kidney diseases. Ongoing international collaborations are advancing research on ERA safety, efficacy, and novel therapeutic strategies, supporting their broader clinical application.
Authors
- Jing Miao (ORCID: https://orcid.org/0000-0003-0642-9740)
- Karim Soliman (ORCID: https://orcid.org/0000-0002-0960-2644)
- Yuh‐Shan Ho (ORCID: https://orcid.org/0000-0002-2557-8736)
- Supawadee Suppadungsuk (ORCID: https://orcid.org/0000-0003-1597-2411)
- Pajaree Krisanapan
- Tibor Fülöp (ORCID: https://orcid.org/0000-0002-3346-7040)
- Wisit Cheungpasitporn
- Charat Thongprayoon
Institutions
- Thammasat University (TH)
- Medical University of South Carolina (US)
- Asia University (JP)
- Mayo Clinic in Arizona (US)
- Ralph H. Johnson VA Medical Center (US)
- Ramathibodi Hospital (TH)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1080/0886022x.2025.2487212
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00